Regeneron Pharmaceuticals, Inc.
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Regeneron Pharmaceuticals, Inc. based on listed parameters only.
The articles listed below published by authors from Regeneron Pharmaceuticals, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
American Journal of Human Genetics |
1 | 0.17 |
|
American Journal of Respiratory and Critical Care Medicine |
1 | 0.01 |
|
Analytical Chemistry |
2 | 2.00 |
|
Annals of Internal Medicine |
1 | 0.10 |
|
Annals of Neurology |
1 | 0.04 |
|
Blood |
1 | 0.05 |
|
Cancer Cell |
1 | 0.05 |
|
Cancer Research |
2 | 0.08 |
|
Cell Host & Microbe |
1 | 0.46 |
|
Diabetes Care |
1 | 0.03 |
|
European Heart Journal |
1 | 0.18 |
|
Gastroenterology |
1 | 0.04 |
|
Gut |
1 | 0.33 |
|
Journal of Clinical Investigation |
3 | 0.23 |
|
Molecular Psychiatry |
1 | 0.04 |
|
Nature |
5 | 0.41 |
|
Nature Communications |
5 | 2.29 |
|
Nature Genetics |
6 | 1.54 |
|
Nature Medicine |
5 | 1.47 |
|
Neuron |
1 | 0.03 |
|
Proceedings of the National Academy of Sciences of the United States of America |
2 | 1.94 |
|
Radiology |
1 | 0.05 |
|
Science Advances |
4 | 2.05 |
|
Science Translational Medicine |
3 | 1.92 |
|
The Lancet Global Health |
1 | 0.03 |
|
The Lancet Oncology |
2 | 0.64 |
|
The New England Journal of Medicine |
3 | 1.09 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.